Compare Logitech International SA (LOGI) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs Repligen Corporation Common Stock — how do they compare? Logitech International SA trades at $101.12 (market cap $14.62B), while Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B). The key difference: Logitech International SA is the larger of the two by market cap, and Logitech International SA pays a 1.61% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Logitech International SA for 92 Days and Repligen Corporation Common Stock for 0 Days on average.
| LOGI | RGEN | |
|---|---|---|
Market Cap | $14.62B | $11.14B |
Volume | 811,529 | 1,259,263 |
Sector | Technology | Health |
52-Week High | $126.69 | $194.57 |
52-Week Low | $85.84 | $102.87 |
Typical Hold Time | 92 Days | 0 Days |
Enterprise Value | $12.95B | $11.02B |
Dividend Yield | 1.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Logitech (LOGI) trades at $101.16, up 2.88% today, with a bullish technical signal from moving averages and support at $101. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.85 beating expectations of $1.26. Fundamentals show robust profitability with a net margin of 16.28% and ROE of 35.29%, while recent news highlights new product launches and partnerships.
The outlook is positive with a consensus price target of $107, offering ~6% upside. Key opportunities include product innovation and market share gains, but risks involve chip shortages and competitive pressures. Analyst sentiment is mixed with 26% buy ratings, suggesting cautious optimism amid execution challenges.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
